Stephen W Fesik

USPTO Granted Patents = 30 (Patent Applications = 15)

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 15)

Average Co-Inventor Count = 5.8

ph-index = 8

Forward Citations = 219(Granted Patents)

Location History:

Gurnee, IL (US) (1997 - 2010)
Nashville, TN (US) (2018 - 2024)

Company Filing History:

18 out of 1,153

Vanderbilt University

patents

12 out of 4,177

Abbott Laboratories Corporation

patents

1 out of 1,535

Boehringer Ingelheim International Gmbh

patents

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

30 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12398097 - WDR5-MYC inhibitors (2025-08-26),

2. 12195472 - Substituted indole Mcl-1 inhibitors (2025-01-14),

3. 12144816 - Substituted indole Mcl-1 inhibitors (2024-11-19),

4. 12060367 - Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer (2024-08-13),

5. 11999716 - WDR5 inhibitors and modulators (2024-06-04),

6. 11596639 - Substituted indole Mcl-1 inhibitors (2023-03-07),

7. 11318137 - Quinazoline compounds as modulators of Ras signaling (2022-05-03),

8. 11208415 - Substituted indole Mcl-1 inhibitors (2021-12-28),

9. 10954193 - Substituted indole Mcl-1 inhibitors (2021-03-23),

10. 10844044 - WDR5 inhibitors and modulators (2020-11-24),

11. 10844032 - Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors (2020-11-24),

12. 10807959 - WDR5-MLL1 inhibitors and modulators (2020-10-20),

13. 10533010 - Substituted indole Mcl-1 inhibitors (2020-01-14),

14. 10501466 - WDR5 inhibitors and modulators (2019-12-10),

15. 10160763 - WDR5 inhibitors and modulators (2018-12-25),

Title: The Inventive Mind of Stephen W Fesik: Promoting Apoptosis Through Innovation

Introduction:

Stephen W Fesik, a prolific inventor hailing from Gurnee, IL (US), has made significant strides in the field of promoting apoptosis through his groundbreaking patents. With a total of 12 patents under his belt, Fesik's work exemplifies innovation at its finest.

Latest Patents:

Fesik's latest patents revolve around N-acylsulfonamide apoptosis promoters. Specifically, N-Benzoyl arylsulfonamides that function as BCL-Xl inhibitors, proving to be instrumental in promoting apoptosis. These inventions highlight Fesik's commitment to advancing medical research and improving treatments for various conditions.

Career Highlights:

A key figure at Abbott Laboratories Corporation, Fesik has not only contributed extensively to the field of apoptosis promotion but has also played a vital role in shaping the company's innovative strategies. His expertise and dedication have undoubtedly left a lasting impact on the field of biomedical research.

Collaborations:

In his professional journey, Fesik has had the privilege of collaborating with notable individuals in the industry. Some of his coworkers, such as Philip J Hajduk and David John Augeri, have worked alongside him, contributing to the success of various projects and patents.

Conclusion:

Stephen W Fesik's remarkable career as an inventor stands as a testament to his unwavering dedication to pushing the boundaries of scientific discovery. His inventive spirit and commitment to excellence continue to inspire advancements in the realm of promoting apoptosis, ultimately benefitting countless individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.